CS Paper Radar

Improving PI-RADS Prediction and Prostate Cancer Detection from Multiparametric MRI with Anatomical Guidance

Seungbin Park, Thibault Heintz, Rachit Saluja, Francesca Khani, Timothy McClure, Daniel Margolis, Mert R. Sabuncu, Heejong Kim

cs.CV cs.AI ·submitted 2026-11-03 01:45 UTC · v1

Abstract

Accurate prediction of Prostate Imaging Reporting and Data System (PI-RADS) scores from multiparametric MRI (mpMRI) remains challenging, more so than clinically significant prostate cancer (csPCa) detection. Given the importance of lesion location in PI-RADS scoring, we evaluated whether incorporating prostate zonal masks improves PI-RADS prediction and csPCa detection across multiple architectures (3D ResNet-18, ResNet-50, and ViT) using a large-scale internal dataset. Anatomical guidance generally improved performance across architectures, with the best results achieved by ResNet-18 with 2-zone guidance for PI-RADS prediction (QWK = 0.511) and ResNet-50 with 5-zone guidance for csPCa detection (AUC = 0.809). Fine-tuned results on external datasets further demonstrated the benefits of anatomical guidance. Furthermore, models with anatomical guidance improved the utility of model-predicted PI-RADS scores for PI-RADS-based csPCa detection (positive defined as PI-RADS>=3). Combining model-predicted and expert-assigned PI-RADS scores significantly increased the AUC from 0.711 to 0.756 (p < 0.05), suggesting that AI-derived PI-RADS scores may provide complementary information to expert assessment for csPCa detection. Overall, our findings highlight the value of incorporating prostate zonal anatomy into deep learning-based prostate MRI assessment.

Closest papers

Nearest neighbours by meaning across the whole index.

Zonal-Aware Prostate Cancer Detection and Classification via Hadamard-Fused Mamba-UNet

eess.IV ·2026-10-29 ·Emadeldeen Hamdan, Gorkem Durak, Muhammed Enes Tasci, Halil Ertugrul Aktas, Fergan Bol +12 more
published similarity 0.72
Abstract · Published in SPIE Medical Imaging - Computer-Aided Diagnosis Conference

Accurate clinically significant prostate cancer (csPCa) detection from prostate MRI requires a detailed understanding of the prostate anatomical context. Deep learning approaches have achieved promising results in zonal and lesion segmentation; however, the joint analysis of prostate zonal anatomy and lesion morphology in a unified framework remains relatively underexplored. In this work, we propose ZH-Mamba, a multi-stage zonal-aware csPCa detection framework consisting of two H-Mamba UNets models for prostate zonal segmentation and lesion localization, followed by an anatomy-aware Convolutional Neural Network classifier for csPCa detection. The proposed model leverages a learnable Hadamard Transform-based fusion mechanism to enhance zonal and lesion feature representations without increasing computational complexity. The learned fusion patterns consistently emphasize prostate regions, suggesting that the proposed fusion captures anatomically relevant feature representations. We demonstrate a strong zonal segmentation performance on the PI-CAI dataset, reaching Dice scores of $\textbf{0.95}$, $\textbf{0.85}$, and $\textbf{0.95}$ for whole gland (WG), peripheral zone (PZ), and transition zone (TZ), respectively, providing robust anatomical priors for downstream csPCa detection. Experimental results on an independent internal dataset confirm the generalization capability of the proposed zonal segmentation model. For lesion localization, the H-Mamba UNet achieves a competitive Dice score of $\textbf{0.70}$. Integrating the zonal masks and lesion localization, the proposed ZH-Mamba framework achieves an AUC of $\textbf{0.86}$, Average Precision ($\mathrm{AP}_{\mathrm{Patient}}$) of $\textbf{0.72}$, and F1 score of $\textbf{0.76}$, demonstrating the effectiveness of zonal-aware csPCa detection.

0.36

Learning Prostate Anatomy at Test Time for Cancer Detection in Micro-Ultrasound

cs.CV cs.LG ·2026-08-20 ·Obed Korshie Dzikunu, Mohammad Mahdi Abootorabi, Mohamed Harmanani, Paul F. R. Wilson, Emma Willis +5 more
code/data similarity 0.68
Abstract

Domain shift across clinical centers using different imaging hardware or acquisition protocols remains a fundamental barrier to deploying deep learning models for prostate cancer (PCa) detection. Existing test-time adaptation (TTA) methods address distribution shift through entropy minimization or augmentation-based self-supervision, correcting for statistical differences in image appearance but ignoring the anatomical structure of the target domain. We propose ANT, a segmentation-guided TTA framework that adapts a pretrained cancer detection encoder to the target domain by solving an auxiliary prostate segmentation task at test time, supervised by pseudo-masks from a frozen pretrained segmentation network. By aligning encoder representations to prostate anatomy in the target domain, ANT corrects domain-specific feature drift while preserving cancer-discriminative structure. The model was trained on 693 patients imaged with an earlier-generation micro-ultrasound scanner in a multi-center clinical trial, and evaluated on 118 patients acquired with a newer-generation system across two centers in another clinical trial. Under a leave-one-center-out protocol with identical evaluation conditions across all methods, ANT improves mean AUC by 2.9% and 3.6% at the biopsy-core and patient levels, respectively, over no adaptation, outperforming TTA baselines. Code is available at: https://github.com/ObedDzik/ant.git.

0.52

Conditional Diffusion-Based Generation of T2-Weighted Prostate MRI for Clinically Significant Prostate Cancer Classification

cs.CV ·2026-11-01 ·Xavier Rafael-Palou, Alejandro Vergara-Richart, Ignacio Iborra Roncales, Carmen Prieto-de-la-Lastra, Andreu Antolin-Redondo +2 more
similarity 0.67
Abstract

Scarce and unrepresentative training data limit the performance of prostate MRI prediction models. Synthetic T2-weighted (T2W) MRI may augment training data containing clinically significant prostate cancer (csPCa) and transition zone (TZ) lesions. In this retrospective, single-center, ethics-committee-approved study, we developed a conditional generative model for T2W prostate MRI extending MAISI-v2 with csPCa class, zonal, and lesion-mask-guided conditioning, incorporating a relative advantage weighted loss fine-tuned on 1,303 patients (1,654 lesions). Fidelity was assessed by incremental ablation, and downstream utility was evaluated with T2W-based csPCa classifiers across five simulated training-data scenarios, each testing 18 synthetic-data configurations. The proposed model reduced Fréchet inception distance (FID) from 13.28 (pretrained MAISI-v2) to $2.04 \pm 0.06$ internally (PI-CAI: $3.83 \pm 0.51$). Synthetic augmentation significantly increased AUC in all five scenarios (+0.027 to +0.088; adjusted $p = 0.016$--$0.043$), though cross-institutional augmentation of PI-CAI yielded a non-significant gain (+0.013; $p = 0.397$). Overall, our model improved T2W MRI fidelity, and synthetic images improved csPCa classification under simulated data constraints, although benefit did not transfer significantly across institutions.

0.21

Zero-Shot Adaptation of Medical Vision Foundation Models for High-Frequency Micro-Ultrasound Prostate Segmentation

cs.CV cs.LG ·2026-08-14 ·Ayusha Abbas, Saram Abbas, Kabita Adhikari
similarity 0.65
Abstract

Prostate cancer claims a life every 80 seconds. Early detection is needed to prevent disease progression, and both PSA density calculation and biopsy decisions rely on knowing the exact boundary of the gland. Conventional ultrasound at 6-12 MHz blurs this boundary, missing one in three high-risk cancers. Micro-ultrasound (29 MHz) improves resolution threefold but introduces dense acoustic speckle that obscures the outer wall; given the same image, two clinicians draw outlines differing by over 10% in area. Supervised methods are costly and generalise poorly across scanners. Can a foundation model segment the prostate with no training data? We present the first zero-shot pipeline for this modality: MedSAM, pre-trained on over 1.5 million medical images, localises the prostate; we then apply CLAHE to sharpen the outer wall, binary dilation to recover missed pixels, and Fourier smoothing (4 modes, s=1.05) to refine the boundary. MedSAM requires a spatial prompt, so we evaluate bounding-box and point-click strategies across 75 patients of the Micro-Ultrasound Prostate Segmentation dataset (2,621 slices). On the 20-patient held-out test set, the pipeline reduces mean boundary-distance error by 45% (Dice 0.749+/-0.043 to 0.865+/-0.029; HD95 217.2+/-36.9 to 120.1+/-26.1 px), reaching Dice 0.859 across the cohort. Its mean overlap shows no significant difference from the three non-expert rater groups (p>0.19), while segmenting 38-52% more consistently (lower inter-patient standard deviation). Point-click prompts fail regardless of placement (best Dice=0.350), because speckle gives no stable local contrast. Only an approximate bounding box is required, so any clinic can deploy it without data collection, annotation, or retraining.

0.04

CONTEXT-PCa: Evaluating the role of clinical context in MRI-based AI for detecting clinically significant prostate cancer (study protocol)

cs.AI ·2026-11-14 ·Shiqi Huang, Weixi Yi, Shaheer Ullah Saeed, Yipei Wang, Wen Yan +7 more
similarity 0.64
Abstract

The objective of this study is to investigate the role of clinical variables - their breadth, source, and quality - in the development, utility, and generalisability of an AI system for bi-parametric MRI (bpMRI)-based diagnosis of clinically significant prostate cancer (csPCa). Clinical context is added to the published PI-CAI-2B image-only model, whose weights are fixed. The study cohort comprises 6,022 biparametric MRI cases from 4,540 patients at University College London Hospitals NHS Foundation Trust (2019-2024), of which 4,834 cases (3,632 patients) are held out for internal testing. Forty-three clinical variables are drawn from structured health records, clinical letters, MRI reports, and automated image measurements. The primary endpoint is the difference in the area under the receiver operating characteristic curve (AUROC) between the image-context and image-only models on the internal test set. Secondary analyses compare combining strategies, the contribution of individual variables, and performance across subgroups. All models are further tested on five external cohorts from primary diagnosis and population-based screening.

0.20

Contrastive uncertainty learning for robust multi-structure segmentation in lower-pelvic MR

cs.CV cs.LG ·2026-10-14 ·Bilal Sidiqi, Yipei Wang, Wen Yan, Shaheer U. Saeed, Daniel C. Alexander +1 more
top venue similarity 0.64
Abstract · UNSURE MICCAI 2026

Boundary delineation of anatomical structures in prostate MRI is often compromised by regional ambiguity. Automated segmentation methods relying on global overlap loss functions tend to be insensitive to surface deviations, leading to significant errors in ambiguous regions. Most existing uncertainty-aware methods treat uncertainty as a post-hoc quality indicator or prediction filter. We propose Contrastive Uncertainty Learning (CUL), a supervised framework that uses predictive uncertainty to directly guide representation learning. Using Monte Carlo Dropout, CUL identifies voxel-wise uncertainty and structures the embedding geometry accordingly: low-uncertainty, correctly predicted features form stable voxels while high-uncertainty or misclassified features are actively repelled, preventing feature collapse at difficult boundaries. We evaluate CUL on a 589-scan 3D prostate MRI multi-structure segmentation task (8 anatomical structures) using a ViT with UperNet decoder architecture. Average Dice ($83.38\%$) remains comparable to the baseline ($83.35\%$), while surface distance decreases significantly ($p<0.001$) across 6 of 8 anatomical structures. A hard-case analysis reveals a $22{\times}$ asymmetry between significantly improved and degraded cases ($18.8\%$ vs $0.9\%$). Ablation studies show that removing uncertainty-guided sample selection eliminates improvements for the transition zone, while replacing the contrastive objective with a boundary loss additionally removes bladder improvements, demonstrating that both uncertainty-guided sampling and the contrastive objective are essential for the observed gains. These findings demonstrate that the proposed uncertainty-guided representation learning is a useful mechanism for reducing the risk of extreme errors in safety-critical medical segmentation

0.30

When Two Tracers Disagree: An Investigation of Multimodal Fusion for Clinical PET/CT Segmentation

cs.CV ·2026-08-19 ·Jack A. Johnson, Bartłomiej W. Papież
publishedcode/data similarity 0.64
Abstract · 10 pages (8 pages main content and 2 pages of references), 2 figures, 2 tables, accepted to MICCAI 2026 Cancer Prevention, Detection, and In…

PSMA and FDG PET/CT visualise complementary biological information in prostate cancer. Combining both tracers could capture heterogeneous tumour phenotypes that may be missed by either alone, yet there is no consensus on effective deep learning architectures for fusing these modalities. We evaluated multimodal image-fusion strategies for automatic whole-body PET/CT lesion segmentation to estimate total tumour burden. Using the public DEEP-PSMA Challenge dataset, we trained tracer-specific 3D nnU-Net baselines and compared (i) early fusion with a single encoder and one decoder (OEOD) or two decoders (OETD), and (ii) intermediate fusion via a dual-encoder cross-attention U-Net (DECA-UNet). Tracer-specific baselines performed strongly (PSMA Dice = 0.93; FDG = 0.81). Fusion yielded mixed results: OEOD produced a combined Dice of 0.90 (on an easier, non-tracer-specific task), whilst the tracer-specific fusion models reached PSMA/FDG = 0.69/0.64 (OETD) and 0.76/0.57 (DECA-UNet). Whilst fusion often provided reasonable PSMA segmentation, FDG performance degraded and no strategy consistently exceeded the single-tracer baselines. Under the evaluated setting, tracer-specific models remain the stronger baseline; clinically useful gains from multimodal fusion will likely require architectures that better preserve tracer specific representations. Our code is available at: https://github.com/JackJ3636/DEEP_PSMA_code

0.45

Spatial Atlas-Informed Loss Ensembles for Whole-Body PSMA PET/CT Metastasis Segmentation

cs.CV ·2026-10-29 ·Grant N. Chau, Bashirul A. Biswas, Biratal Wagle, Matthew E. Maeder, Michael S. Leapman +2 more
similarity 0.63
Abstract · 21 pages, 6 figures

Existing whole-body PSMA PET/CT prostate metastasis segmentation methods generally rely on images alone, without explicitly incorporating where metastases tend to occur. We investigate whether a population metastasis atlas can improve lesion detection when integrated into model training. We constructed voxel-wise mean and standard deviation maps from 375 expert-annotated training scans and used them to weight the cross-entropy loss of an nnU-Net. The additional penalties for missed lesions and false positives depend on spatial atlas statistics and diminish as predictions become confidently correct. Seven configurations were compared on validation data; three were combined by majority voting into SAILS (Spatial Atlas-Informed Loss enSemble). We compared SAILS with a baseline nnU-Net and inference-time atlas fusion on AutoPET~III (110 disease-positive cases) and Deep-PSMA (100 external cases). No atlas or registration is needed at inference. Results: On AutoPET~III, SAILS improved whole-body Dice (0.531 vs. 0.520; p=0.006), reduced missed-lesion volume (9.5 vs. 12.1 cc/case; p<0.01), and increased pooled lesion sensitivity (0.857 vs. 0.843; p=0.004). On Deep-PSMA, SAILS detected 126 additional reference lesions (sensitivity 0.769 vs. 0.751; p<0.001), without a significant whole-body Dice change (-0.009; p=0.36). High-risk bone Dice improved in both cohorts (0.576 vs. 0.552 and 0.667 vs. 0.653; both p<0.01). False-positive volume increased by 2.3 and 18.2 cc/case, respectively (p<0.001). Atlas-weighted training improves lesion detection, especially in high-risk bone, without test-time atlas registration, but increases false positives.

0.31